CD6 and cancer: This dual role of CD5 and CD6 as both immunomodulatory and microbial PRR receptors is supported by pre-clinical models of infection, autoimmunity and cancer involving Cd5- and Cd6-deficient mouse lines, as well as infusion of wild-type mice with soluble CD5 and CD6 proteins (24–26).